Randomized Controlled Trial to Determine the Efficacy of Long-Term Growth Hormone Treatment in Severely Burned Children
Ludwik K. Branski(The University of Texas Medical Branch at Galveston), Marc G. Jeschke(Thrombosis and Atherosclerosis Research Institute), Ronald P. Mlcak(Shriners Hospitals for Children - Galveston), Oscar E. Suman(The University of Texas Medical Branch at Galveston), Jong O. Lee(University of North Carolina at Chapel Hill), Walter J. Meyer(National Institutes of Health), Gordon L. Klein(The University of Texas Medical Branch at Galveston), David L. Chinkes(Shriners Hospitals for Children - Galveston), Rene Przkora(Eli Lilly (United States)), Ted T. Huang(Eli Lilly (United States)), Robert E. Barrow(Child Mind Institute), Gabriela A. Kulp(The University of Texas Medical Branch at Galveston), David N. Herndon(Joseph M. Still Research Foundation)
Cited by 95
Related Papers
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
The leading causes of death after burn injury in a single pediatric burn center
|Critical Care|2009|376
Intramuscular and Liver Triglycerides Are Increased in the Elderly
|The Journal of Clinical Endocrinology & Metabolism|2004|273
Non-cystic Fibrosis Bronchiectasis
|Unknown|2012|254
Intensive Insulin Therapy in Severely Burned Pediatric Patients: A Prospective Randomized Trial
|American Journal of Respiratory and Critical Care Medicine|2010|210